Axalbion SA
Pharmaceuticals · Lausanne, Vaud
Axalbion SA is a Swiss pharmaceuticals company based in Lausanne, Canton of Vaud, listed in the Swiss commercial register since 2017 (UID CHE-455.452.655).
Board members & signatories
- Olivier Poirot — Präsident des Verwaltungsrates
- Vitins Peter — Mitglied des Verwaltungsrates
- Rüedi Marco — Direktor
Registered purpose
la société a pour but la recherche et le développement de produits, de matériel, de méthodes, de procédures et d'outils technologiques en matière médicale et pharmaceutique. Le développement et l'enregistrement de droits de propriété intellectuelle dans les mêmes domaines. La production et la commercialisation de produits, de matériel et d'outils technologiques en matière médicale et pharmaceutiqu…
Source: Swiss commercial register (Zefix / SOGC) and Alpintel analysis · Data as of March 2026
What Axalbion does
OFFERING
Axalbion develops AX-8, a TRPM8 agonist aimed at treating refractory chronic cough (RCC). This therapy is designed for topical delivery to sensory nerve termini involved in cough hypersensitivity, with proof-of-concept studies indicating early efficacy and tolerability. Global clinical trials for AX-8 are planned to begin in 2027.
Unlock the full analysis →Similar companies
- AlphaBio SA — Pharmaceuticals · Genève
- Alnylam Switzerland GmbH — Pharmaceuticals · Zug
- Alloy Therapeutics (Switzerland) AG — Pharmaceuticals · Allschwil
- Axon Lab AG — Medical Devices & Equipment · Dättwil AG
- Alphathera AG — Pharmaceuticals · Basel
- Anaveon AG — Pharmaceuticals · Basel
Find every pharmaceuticals company in Switzerland
Alpintel searches all 710,000 Swiss companies with AI — filter by industry, size, revenue, region and ownership in seconds.
family-owned pharmaceuticals companies with 50+ employees…Search →Full profiles from CHF 49/month · Cancel anytime